Dr. Reddy's Laboratories Limited
RDY
$12.22
$0.110.91%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -7.40% | -1.76% | 6.73% | 10.65% | 13.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.40% | -1.76% | 6.73% | 10.65% | 13.14% |
| Cost of Revenue | 8.67% | 11.51% | 17.52% | 18.37% | 16.98% |
| Gross Profit | -19.20% | -11.16% | -0.68% | 5.35% | 10.48% |
| SG&A Expenses | 5.78% | 7.94% | 9.97% | 12.88% | 15.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 25.65% | 5.28% | -59.93% | -48.81% | -53.93% |
| Total Operating Expenses | 5.05% | 7.36% | 11.48% | 13.85% | 15.46% |
| Operating Income | -53.03% | -33.83% | -9.75% | -0.28% | 5.38% |
| Income Before Tax | -48.85% | -30.95% | -3.63% | 2.27% | 4.11% |
| Income Tax Expenses | -58.09% | -38.64% | -11.90% | -3.68% | 15.08% |
| Earnings from Continuing Operations | -45.69% | -28.31% | -0.85% | 4.25% | 0.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 158.26% | 152.06% | 156.51% | 139.22% | -- |
| Net Income | -44.43% | -26.76% | 1.37% | 6.56% | -0.29% |
| EBIT | -53.03% | -33.83% | -9.75% | -0.28% | 5.38% |
| EBITDA | -41.33% | -25.25% | -5.03% | 3.65% | 7.49% |
| EPS Basic | -44.43% | -26.72% | 1.40% | 6.56% | -0.34% |
| Normalized Basic EPS | -49.54% | -30.11% | -2.55% | 3.83% | 5.68% |
| EPS Diluted | -44.39% | -26.67% | 1.46% | 6.58% | -0.31% |
| Normalized Diluted EPS | -49.49% | -30.05% | -2.46% | 3.91% | 5.72% |
| Average Basic Shares Outstanding | 0.03% | -0.03% | -0.03% | 0.01% | 0.05% |
| Average Diluted Shares Outstanding | -0.05% | -0.10% | -0.09% | -0.04% | 0.01% |
| Dividend Per Share | -8.44% | -8.44% | -4.05% | -4.05% | -4.05% |
| Payout Ratio | 0.73% | 0.31% | -0.05% | -0.10% | -0.01% |